Semaglutide treats type 2 diabetes and can support weight loss with diet and exercise. It works by mimicking glucagon-like peptide-1 (GLP-1) to boost insulin and reduce appetite. Compounded ...

In a recent study published in the International Journal of Obesity, researchers assessed the effectiveness of semaglutide dosages between 0.25 and 2.4 mg in overweight or obese people for up to one ...

Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older adults. A small study found that up to 40% of weight loss from semaglutide ...

When it comes to semaglutide, withdrawal symptoms can involve changes related to weight, appetite, blood sugar levels, and cardiovascular health. When you regularly take a medication that alters ...

A once-weekly, 2.4-mg dose of subcutaneous semaglutide, a glucagon-like peptide-1 receptor agonist, is used to treat obesity in adults, but assessment of the drug in adolescents has been lacking. In ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Some of those taking Ozempic or Wegovy are learning that too much of a good thing is never good. Semaglutide, the medication prescribed under the brand names Ozempic, for treating Type 2 diabetes, and ...

GLP-1s, or glucagon-like peptide-1 medications, have shown promise at treating obesity, a condition that affects a large swath of Americans and contributes to worse health outcomes. But the drugs are ...